ABIC Score for Alcoholic Hepatitis
Age, serum Bilirubin, INR, and serum Creatinine (ABIC) score predicts 90-day mortality in alcoholic hepatitis. Identifies low-, intermediate-, and high-risk patients.
Score interpretation
Low risk — 90-day survival >90%
→ Supportive care; nutritional support; alcohol abstinence. Steroids generally not required.
Intermediate risk — 90-day survival ~70%
→ Consider corticosteroids (prednisolone 40 mg/day × 4 weeks); reassess with Lille score at 7 days
High risk — 90-day survival <25%
→ Consider corticosteroids with early specialist review; liver transplant evaluation where appropriate
Interpretation bands for the ABIC Score. Apply clinical judgement and local guidance.
References
- Dominguez M et al. A new scoring system for prognostic stratification of patients with alcoholic hepatitis. Am J Gastroenterol. 2008;103(11):2747–2756.
Related
Curated clinical cross-links plus same-class fallbacks.
- Methotrexate (Dermatology — Psoriasis) · Disease-Modifying Antirheumatic / Immunosuppressant
- Acetazolamide (Ménière's Disease) · Carbonic Anhydrase Inhibitor (Diuretic)
- Zinc acetate · Zinc salt (Wilson's disease)
- Sulfasalazine · Aminosalicylate / Disease-Modifying Antirheumatic Drug (DMARD)
- Entecavir · Antiviral — Hepatitis B (Nucleoside Analogue)
- Tenofovir (TDF/TAF) · Antiviral — Hepatitis B (Nucleotide Analogue)
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.